Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses.
暂无分享,去创建一个
[1] J. Meyerovitch,et al. Association between Psoriasis and the Metabolic Syndrome , 2008, Dermatology.
[2] Erin G Harper,et al. Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines , 2007, Current rheumatology reports.
[3] W. Aronow,et al. Incidence of New Stroke or New Myocardial Infarction or Death at 39-Month Follow-Up in Patients with Diabetes Mellitus, Hypertension or Both with and without Microalbuminuria , 2007, Cardiology.
[4] Anna Viner,et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. , 2007, Journal of the American Academy of Dermatology.
[5] E. Schiffrin,et al. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. , 2007, Clinical science.
[6] E. Sijbrands,et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. , 2007, Atherosclerosis.
[7] M. Rizzo,et al. Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. , 2006, Archives of medical research.
[8] Daniel B. Shin,et al. Prevalence of cardiovascular risk factors in patients with psoriasis. , 2006, Journal of the American Academy of Dermatology.
[9] Daniel B. Shin,et al. Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.
[10] C. Ritchlin,et al. Metabolic disorders in patients with psoriasis and psoriatic arthritis , 2006, Current rheumatology reports.
[11] M. Weichenthal,et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis , 2006, Archives of Dermatological Research.
[12] J. Tuomilehto,et al. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[13] A. Syrenicz,et al. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. , 2006, Neuro endocrinology letters.
[14] G. Ning,et al. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. , 2006, Diabetes research and clinical practice.
[15] P. Mease,et al. Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. , 2006, Journal of the American Academy of Dermatology.
[16] J. Tuomilehto,et al. The Impact of History of Hypertension and Type 2 Diabetes at Baseline on the Incidence of Stroke and Stroke Mortality , 2005, Stroke.
[17] R. Stern,et al. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. , 2005, Journal of the American Academy of Dermatology.
[18] S. Feldman,et al. The comorbid state of psoriasis patients in a university dermatology practice , 2005, The Journal of dermatological treatment.
[19] A. Kimball,et al. The Psychosocial Burden of Psoriasis , 2005, American journal of clinical dermatology.
[20] R. Stern,et al. The prevalence of psoriasis in African Americans: results from a population-based study. , 2005, Journal of the American Academy of Dermatology.
[21] Edward H Livingston,et al. Effect of diabetes and hypertension on obesity-related mortality. , 2005, Surgery.
[22] V. Ho. The use of ciclosporin in psoriasis: a clinical review , 2004, The British journal of dermatology.
[23] M. Goodfield,et al. Objective assessment of compliance with psoriasis treatment. , 2004, Archives of dermatology.
[24] P. Lisi,et al. Statistical association between psoriasis and diabetes: Further results , 1975, Archives of Dermatological Research.
[25] H. Ollendorff-Curth. Psoriasis und Diabetes mellitus , 1966, Archiv für klinische und experimentelle Dermatologie.
[26] Women's high CRP levels can predict hypertension. , 2004, Healthcare benchmarks and quality improvement.
[27] J. Pankow,et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.
[28] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[29] E. Christophers. Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.
[30] M. Lebwohl,et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. , 2001, Archives of dermatology.
[31] T. Chu. Better patient compliance in psoriasis. , 2000, The Practitioner.
[32] R. Brodell,et al. A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. , 1999, Postgraduate medicine.
[33] S. Chevret,et al. Long-term safety of cyclosporine in the treatment of psoriasis. , 1996, Archives of dermatology.
[34] W. Willett,et al. Diet and risk of basal cell carcinoma of the skin in a prospective cohort of women. , 1992, Annals of epidemiology.
[35] R. Freinkel,et al. Systemic absorption of topical steroids. Metabolic effects as an index of mild hypercortisolism. , 1986, Archives of dermatology.
[36] W. Willett,et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. , 1986, American journal of epidemiology.
[37] M. H. Brownstein. Psoriasis and diabetes mellitus. , 1966, Archives of dermatology.
[38] R. Fusaro,et al. PSORIASIS VULGARIS. I. A CLINICAL SURVEY OF THE ASSOCIATION WITH DIABETES MELLITUS. , 1964, Archives of dermatology.
[39] S. H. Gibson,et al. Diabetes and psoriasis. , 1956, A.M.A. archives of dermatology.